Why is the Defense Department Withholding Funding for USAMRIID and CCDC Chemical Biological Center?
Today, U.S. Senators Chris Van Hollen and Ben Cardin as well as Congressmen David Trone, Dutch Ruppersberger, Jamie Raskin, and ...
Tag: USAMRIID
First-Ever Therapeutic Antibody Cocktail for Sudan Virus Shows Promise in Animal Studies
Army scientists working with partners from industry and academia have developed an experimental treatment that protects animals from Sudan virus, ...
Henry Eigelsbach, Microbiologist Known for Tularemia Research, Dies at 100
Renowned microbiologist Henry “Hank” Eigelsbach died of natural causes on December 6, 2019 at the age of 100. The former ...
CDC Approves Partial Resumption of USAMRIID Select Agent Research
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) will resume limited research, following a successful recent inspection by ...
USAMRIID Study Leads to Approval of New Smallpox Vaccine
A new vaccine approved in the U.S. on Sept. 24 prevents both smallpox and the related disease monkeypox in adults. ...
Cutting Edge Chemical and Biological Defense Science: Hot Topics at CBD S&T 2019
In a few short weeks, the Defense Threat Reduction Agency (DTRA) will host the 2019 Chemical and Biological Defense Science ...
DoD Inspector General to Reevaluate Select Agent Facilities, Biosafety Oversight
The Department of Defense Office of the Inspector General (DoD OIG) is conducting a Follow-Up Evaluation of DoD Biological Select ...
Research Halted at USAMRIID Over Biosafety Issues
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), the only Biosafety Level 4 laboratory in the Department of ...
USAMRIID Seeks Isolation and Purification of Ovatoxins
The U.S. Army Medical Research Acquisition Activity (USAMRAA) is conducting market research to obtain information regarding services provide Isolation and ...
Ology Bioservices Awarded DoD Contract for Countermeasures Against Bioweapons
The Department of Defense (DOD), through its Platforms for Rapid Integrated Solutions for Medical Countermeasures (PRISM) office, has awarded Ology ...
SIGA, USAMRIID Enter Agreement to Evaluate Post-Exposure Prophylactic for Smallpox
SIGA Technologies, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United ...
Collaboration Among BARDA, DTRA, USAMRIID and Spero to Advance SPR994
Spero Therapeutics, Inc. today announced that it was awarded funding of $15.7 million, with the potential for up to an additional $28.5 ...
USAMRIID Temporarily Halts Activity at BSL-3 and BSL-4 Laboratories
The U.S. Army for Medical Research Institute of Infectious Diseases (USAMRIID) has suspended Biosafety Level 3 (BSL-3) and Biosafety Level ...
USAMRIID Awards Select Agent Research Reagents Contract
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) is the Department of Defense's (DoD) lead laboratory for medical ...
MIT, USAMRIID Develop Algorithm for Early Warning of Exposure to Pathogens
Overt symptoms of many diseases often do not manifest until days after a person's initial exposure to the causative pathogen, ...
Monkeypox in Nigeria: The Value of Local Surveillance and Genetic Sequencing
Scientists performed genetic sequencing of patient samples from the monkeypox virus (MXPV) outbreak in Nigeria, revealing that the outbreak likely ...
USAMRIID-Bavarian Nordic Smallpox Vaccine Phase 3 Study
Concept drawing of vaccinia. Credit: Shutterstock Bavarian Nordic announced on Feb. 6 the results of a ...
Enhancing the Efficacy of Adenovirus-5 Vectored Ebola Virus Vaccines
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Virology Division, Pathogenesis and Immunology Branch has been tasked by ...
Modernization of USAMRIID’s Biodefense Lab Management System
The U.S. Medical Research Army Acquisition Activity (USAMRAA) is conducting market research to identify parties capable of modernizing and providing ...
DoD to Study Omadacycline as Countermeasure for Plague, Anthrax
3D rendering of Yersinia pestis. Credit: Shutterstock Paratek Pharmaceuticals this week announced a new cooperative research ...
ADVERTISEMENT.
